Cariprazine-d8

• CAT Number: S000184
• CAS Number: 1308278-50-3
• Molecular Formula: C21H24D8Cl2N4O
• Molecular Weight: 435.46
• Purity: ≥95%
• IUPAC Name: 3-[4-[2,2-dideuterio-2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-bis(trideuteriomethyl)urea
• InChI: InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)/i1D3,2D3,11D2
• InChIKey: KPWSJANDNDDRMB-KEWKYEQZSA-N
• SMILES: [2H]C([2H])([2H])N(C(=O)NC1CCC(CC1)CC([2H])([2H])N2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl)C([2H])([2H])[2H]

Cariprazine-d8 (CAS: 1308278-50-3), a premium pharmaceutical research compound designed for advanced psychopharmacological and antipsychotic studies. As a deuterated analog of Cariprazine, it offers enhanced stability and improved pharmacokinetic properties. Cariprazine-d8 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for schizophrenia, bipolar disorder, and other psychiatric conditions. Trusted by leading laboratories, Cariprazine-d8 is your go-to solution for cutting-edge mental health research. Unlock new possibilities in the treatment of psychiatric disorders with Cariprazine-d8, where innovation meets reliability.

Reference

[1]. Seneca N, et al. Occupancy of dopamine D2 and D3 and serotonin 5-HT1A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography. Psychopharmacology (Berl). 2011 Dec;218(3):579-8.
[Content Brief]